Russian Federal Drug Control Service Liquidation Commission
| Primary URL | Location | Industry | fskn[.]gov[.]ru |
Country
Russia
|
Government - National
|
|---|
Profile
The Russian Federal Drug Control Service Liquidation Commission, also known as the Federal Drug Control Service of Russia, was a federal executive body tasked with overseeing the nation’s drug control policy and enforcement efforts. Its primary functions included preventing the illicit production, trafficking, and abuse of narcotics and psychotropic substances, coordinating law‑enforcement actions across various agencies, and conducting investigative operations to dismantle drug‑related criminal networks. The service also engaged in international cooperation, sharing intelligence and best practices with foreign counterparts to combat trans‑national drug crime.
Headquartered in Russia, the agency operated as a nationwide authority with a mandate that extended to all federal subjects, enabling it to implement uniform drug‑control standards throughout the country. As a specialised law‑enforcement body, it maintained units focused on intelligence gathering, forensic analysis, and operational support, which allowed it to respond to emerging threats in the narcotics market. The commission’s work was guided by Russian federal legislation on drug control and was aligned with the country’s broader public‑health and security objectives.
Distinguishing attributes of the organisation included its exclusive focus on narcotics regulation, setting it apart from broader interior‑affairs ministries that handled general crime. Its regulatory role encompassed licensing of legitimate pharmaceutical activities, monitoring of precursor chemicals, and enforcement of sanctions against violations. The service positioned itself as the central node for drug‑policy implementation, leveraging specialised training programs for its personnel and maintaining a dedicated forensic laboratory to substantiate evidentiary requirements in court proceedings.
Structurally, the Federal Drug Control Service was a direct subordinate of the Government of the Russian Federation, reporting to the Prime Minister and ultimately accountable to the President. Following its abolition in 2016, the Liquidation Commission was established to wind down the agency’s affairs, transferring its personnel, assets, and operational responsibilities to the Ministry of Internal Affairs. This transition marked the end of an independent federal drug‑control entity, with its former functions now integrated into the internal‑affairs structure of the Russian state.
